NanoViricides
NNVC
$1.10
Share price
-0.90%
Change (1 day)
-17.29%
Change (1 year)
Categories
NanoViricides (NNVC) - Total debt
Total debt on the balance sheet as of September 2023 : $1.5 M
According to NanoViricides's latest financial reports the company's total debt is $1.5 M. A company’s total debt is the sum of all current and non-current debts.
NanoViricides - Total debt on balance sheet (from 2006 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-06-30 | $0.09 M | -0.54% |
| 2021-06-30 | $0.09 M | -91.68% |
| 2020-06-30 | $1.14 M | |
| 2017-06-30 | $3.95 M | -54.04% |
| 2016-06-30 | $8.6 M | 19.87% |
| 2015-06-30 | $7.18 M | 77.86% |
| 2014-06-30 | $4.03 M | 16.42% |
| 2013-06-30 | $3.46 M | |
| 2006-06-30 | $0.91 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $24.98 B | 1,665,700.00% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 2,336,900.00% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 3,827,166.67% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | 1,529,026.67% | 🇬🇧 UK |
 Novavax NVAX | $0.22 B | 15,172.07% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.82 B | 54,909.87% | 🇺🇸 USA |